Is Melanotan II (Afamelanotide) nasal spray safe to use for tanning?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 7, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Melanotan II Nasal Spray Is Not Safe for Tanning

Melanotan II nasal spray is not safe to use for tanning purposes and should be avoided due to significant health risks including potential development of melanoma, systemic toxicity, and other serious adverse effects.

Safety Concerns with Melanotan II

Melanoma Risk

  • Multiple case reports document melanoma development associated with Melanotan II use:
    • A 20-year-old woman developed cutaneous melanoma after a 3-4 week course of self-injections with Melanotan II in combination with sunbed use 1
    • Four case reports have described melanomas emerging from existing moles during or shortly after Melanotan use 2
    • A 22-year-old female developed oral mucosal malignant melanoma after using Melanotan II nasal spray 3

Regulatory Status

  • Melanotan II is unlicensed and its sale is illegal in the United Kingdom and many other countries 3
  • Multiple national health organizations have issued safety warnings regarding the use of Melanotan I and II 2

Additional Health Risks

  • Systemic toxicity with sympathomimetic excess and rhabdomyolysis has been reported:
    • A case of a 39-year-old male who developed tachycardia (HR 146 bpm), hypertension, mydriasis, diaphoresis, anxiety, and severe rhabdomyolysis (CPK elevated to 17,773 IU/L) requiring ICU admission after Melanotan II injection 4
  • Other concerning risks include:
    • Transmission of infectious diseases
    • Use of potentially contaminated products
    • Polypharmacy interactions
    • Increased sunbed exposure 5

Tanning and Skin Cancer Risk

UV Exposure and Skin Cancer

  • The U.S. Preventive Services Task Force notes that UV exposure increases the risk for skin cancer among people with all skin types, especially fair-skinned individuals 6
  • Intermittent or intense sun exposure is a greater risk factor for melanoma than chronic exposure 6
  • Preventing sunburn, especially in childhood, may reduce the lifetime risk for melanoma 6

Sunbeds and Tanning

  • The effects of sunlamps and tanning beds on the risk for melanoma are unclear due to limited study design and conflicting results 6
  • People who use sunscreen alone could increase their risk for melanoma if they increase time spent in the sun 6

Safe Alternatives for Sun Protection

Instead of using Melanotan II, the following evidence-based sun protection measures are recommended:

  • Avoiding direct exposure to midday sun (between 10:00 a.m. and 4:00 p.m.)
  • Covering skin with protective clothing (broad-brimmed hats, long-sleeved shirts, long pants, and sunglasses)
  • Using sunscreens that block both UVA and UVB light 6

Conclusion for Healthcare Providers

When counseling patients about tanning:

  • Be aware that Melanotan II is part of a "tanning culture" in certain subpopulations 2
  • Educate patients about the significant risks of unregulated Melanotan II products
  • Emphasize that these products have not undergone proper safety testing
  • Recommend safe sun protection practices instead
  • Consider screening patients with suspicious skin changes who report Melanotan use

Healthcare providers should maintain a high index of suspicion for melanoma in patients who report using Melanotan II, particularly if they have new or changing pigmented lesions.

References

Research

Melanoma associated with the use of melanotan-II.

Dermatology (Basel, Switzerland), 2014

Research

Melanotan II nasal spray: a possible risk factor for oral mucosal malignant melanoma?

International journal of oral and maxillofacial surgery, 2025

Research

Melanotan II injection resulting in systemic toxicity and rhabdomyolysis.

Clinical toxicology (Philadelphia, Pa.), 2012

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.